StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences gross margin

Gross margin is gross profit as a percentage of revenue.

Integra LifeSciences's gross margin for the twelve months ending Sep 30, 2026 was 52.4%. For fiscal 2025 it was 50.9%, against 54.8% the year before. The highest annual figure on record is 64.8% in fiscal 2016.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202550.9%−3.9
FY2024Dec 31, 202454.8%−2.6
FY2023Dec 31, 202357.4%−4.9
FY2022Dec 31, 202262.3%+1.0
FY2021Dec 31, 202161.2%−0.8
FY2020Dec 31, 202062.0%−0.8
FY2019Dec 31, 201962.8%+1.6
FY2018Dec 31, 201861.2%−2.2
FY2017Dec 31, 201763.3%−1.5
FY2016Dec 31, 201664.8%+1.8
FY2015Dec 31, 201563.0%+1.0
FY2014Dec 31, 201462.0%+2.1
FY2013Dec 31, 201359.9%−2.3
FY2012Dec 31, 201262.2%+0.5
FY2011Dec 31, 201161.7%−1.7
FY2010Dec 31, 201063.4%−0.7
FY2009Dec 31, 200964.1%+2.7
FY2008Dec 31, 200861.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202651.0%−0.4
Q2 FY2026Jun 30, 202652.5%+2.1
Q1 FY2026Mar 31, 202655.4%+4.6
Q4 FY2025Dec 31, 202550.8%−5.5
Q3 FY2025Sep 30, 202551.5%−1.1
Q2 FY2025Jun 30, 202550.4%−3.7
Q1 FY2025Mar 31, 202550.8%−5.3
Q4 FY2024Dec 31, 202456.3%−0.8
Q3 FY2024Sep 30, 202452.6%−4.5
Q2 FY2024Jun 30, 202454.0%−0.3
Q1 FY2024Mar 31, 202456.1%−5.1
Q4 FY2023Dec 31, 202357.0%−5.8
Q3 FY2023Sep 30, 202357.1%−4.4
Q2 FY2023Jun 30, 202354.3%−8.4
Q1 FY2023Mar 31, 202361.1%−1.0
Q4 FY2022Dec 31, 202262.8%+1.4
Q3 FY2022Sep 30, 202261.5%−1.2
Q2 FY2022Jun 30, 202262.7%+1.5
Q1 FY2022Mar 31, 202262.1%+2.6
Q4 FY2021Dec 31, 202161.5%−0.7
Q3 FY2021Sep 30, 202162.7%−0.9
Q2 FY2021Jun 30, 202161.2%+2.0
Q1 FY2021Mar 31, 202159.5%−2.8
Q4 FY2020Dec 31, 202062.2%−0.0
Q3 FY2020Sep 30, 202063.6%+1.2
Q2 FY2020Jun 30, 202059.2%−3.3
Q1 FY2020Mar 31, 202062.3%−1.8
Q4 FY2019Dec 31, 201962.2%+0.4
Q3 FY2019Sep 30, 201962.4%+1.5
Q2 FY2019Jun 30, 201962.6%+0.1
Q1 FY2019Mar 31, 201964.2%+4.5
Q4 FY2018Dec 31, 201861.8%+2.0
Q3 FY2018Sep 30, 201860.8%−2.7
Q2 FY2018Jun 30, 201862.4%−2.5
Q1 FY2018Mar 31, 201859.6%−6.9
Q4 FY2017Dec 31, 201759.8%−6.8
Q3 FY2017Sep 30, 201763.5%–
Q2 FY2017Jun 30, 201764.9%–
Q1 FY2017Mar 31, 201766.5%–
Q4 FY2016Dec 31, 201666.6%–

More Integra LifeSciences figures

See a number that looks wrong?